Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-09-19

Clinical Trial Update: Polypill Versus Metformin in New Onset Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing a polypill with metformin for new-onset Type 2 diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polypill
  • metformin (metformin)

Snippet

Sponsor: George Medicines PTY Limited | Conditions: Type 2 Diabetes | Phase 2 | Status: WITHDRAWN